Spanish initiative to promote the responsible use of veterinary medicines, Vetresponsable

---

Maria B Jaureguizar

Vet+i Foundation- Spanish Technology Platform for Animal Health, Spain

: J Vet Sci Med Diagn

Abstract

---

Vetresponsable has developed specific guidelines on responsible use of veterinary medicine products for food-producing, companion animals and wildlife, also a Website on responsible use www.vetresponsable.es. Additionally, the initiative participates in the implementation of the “Spanish Plan to minimise the risk of selection and dissemination of antimicrobial resistance”. It has a communication plan addressed to vets, farmers, pet owners and Vetstudents: Vetresponsable has already visited almost all the Veterinary Schools in Spain. The Spanish Agency of Medicines and Sanitary Products (AEMPS) has joined it and participated as a speaker in these courses. Highly valued by attendees and Deans/professors, the programme has a practical approach.

Biography

---

María B Jaureguízar is currently the General Manager of the Spanish Technology Platform for Animal Health, www.vetmasi.es a project called Vet+i Foundation. After graduation from the Veterinary Faculty of the Complutense University of Madrid, she started her career in the industry of animal health in Spain (MDS Animal Health), in the pharmacovigilance area doing: Technical training for delegates in the pharmacovigilance notification; data collection and corporate communications in English and through the PV Works data base, in relation to suspected adverse events or lack of efficacy caused by medicines; preparation and submission of Periodic Safety Update Report (PSUR) to the Spanish Agency for Medicines and Sanitary Products (AEMPS); translation of medicine labels and pharmacovigilance final reports; direct contact and discussion of our cases with veterinarians, technicians and delegates; solution of veterinary medicine problems like vaccination procedures, interpretation of serology, prevention protocols of ectoparasites how to confront a suspected lack of expected efficacy or a suspected adverse reactions; attendance at conferences of MSD technicians; compiling of reports on side effects received and; control, filing and updating of confidential information relating to pharmacovigilance.

Email: secretaria@vetmasi.es